Inna Perutski

Title: Inna Perutski: Innovator in Pharmaceutical Chemistry

Introduction

Inna Perutski is a notable inventor based in Hadera, Israel. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel forms of ibandronic acid. Her work has implications for the treatment of various medical conditions, showcasing her dedication to advancing healthcare through innovation.

Latest Patents

Inna holds a patent for "Solid and crystalline ibandronic acid." This patent provides novel crystalline and amorphous forms of ibandronic acid, along with methods for their preparation. Additionally, it includes pharmaceutical compositions containing these forms and methods for purifying and assaying ibandronic acid in any crystalline or amorphous state. This patent highlights her expertise in creating effective pharmaceutical solutions.

Career Highlights

Inna is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her role at Teva allows her to leverage her skills and knowledge in pharmaceutical development, contributing to the company's mission of improving patient health worldwide.

Collaborations

In her career, Inna has collaborated with esteemed colleagues such as Thomas Bayer and Ben-Zion Dolitzky. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.

Conclusion

Inna Perutski's contributions to pharmaceutical chemistry, particularly through her patent on ibandronic acid, demonstrate her commitment to innovation in healthcare. Her work continues to impact the industry positively, paving the way for future advancements.